Project Management Institute Announces List of 50 Next Generation Leaders to Watch
Project Management Institute (PMI) today announced its first annual Future 50 list, which features the 50 next generation leaders that are creating, building, and transforming the world through notable projects. The 50 young standout project leaders highlighted in the specially dedicated July/August issue of PM Network® magazine represent the wave of change and talent around the globe—a youthquake that will reshape the future and accelerate innovation in the here and now. Honorees include groundbreaking achievements from people across a variety of industries and countries, including Director Greta Gerwig, Laura Jones from the Special Olympics and Miishe Addy from Jetstream Africa.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200713005075/en/
According to PMI’s recent Pulse of the Profession ® report, only 40 percent of organizations say they prioritize attracting and hiring the young generation of project professionals. But what the Future 50 list highlights is that this next generation will be crucial to driving value for businesses and society now and in the future.
“As a new generation of leaders rise around the world we are seeing them have additional guiding principles and motivations when compared to earlier generations. Organizations are already rethinking how they can attract, retain and help foster this generation of talent,” said Sunil Prashara, President and CEO of Project Management Institute. “This next generation of project leaders are deeply committed to driving change across the world – from having a deep sense of social responsibility and improving the environment to driving diversity and inclusion. The 50 individuals featured on this list are some of the biggest change makers of their generation. They exemplify the power and transformative change that can happen through projects.”
As part of the July/August issue of PM Network, PMI interviewed this year’s Future 50 winners and other seasoned professionals around the globe to uncover ways to encourage this next generation of talent. The issue also outlines six rules to harness the power of these future-focused professionals, including igniting a learning culture; picking up the pace of development; a flatter, more communicative leadership team; more purpose-driven work; and constant, iterative feedback.
To identify this year’s Future 50 honorees, PMI reached out to hundreds of experts and stakeholders across the globe for nominations. A special committee vetted the rising project professionals and narrowed the options. Finalists were then individually researched and/or interviewed to create a list that represents the full spectrum of regions, industries and achievements in The Project Economy – where work increasingly centers around executing projects both large and small. While some honorees are Project Management Professional (PMP)® credential holders, others would not even describe themselves as project managers. What unites the Future 50 is a commitment to project work as the foundation of positive impact, for today and tomorrow.
To learn more about the complete list of honorees and the rules to drive this next generation of talent, visit PMI.org/Future50.
The 50 Future Leaders to Watch:*
- Abdullah Seflan, Saudi Aramco
- Ada Osakwe, Qantas
- Adam Fahrenkopf, Google
- Alagesan Hanippuya, RHB Banking Group
- Andrew Walters, National Australia Bank
- Arman Köklü, GE
- Bilel Manai, Al Bawsala
- Boyan Slat, The Ocean Cleanup
- Rep. Bryan Steil, United States House of Representatives
- Charlyn Johnson, UK Ministry of Justice
- Diletta Invernizzi, Jacobs
- Gabriel Costa Caldas, Alpha Ports
- Geetha Gopal, Panasonic
- Gillian Dowds, BAE Systems Maritime
- Gregory Daniels, Zoom
- Greta Gerwig, Director
- Greta Thunberg, Climate Change Activist
- Hayden Brown, Upwork
- Janeen Blige, IBM
- Jaspreet Dol, DXC
- Jenk Oz, Thred
- Jia Song, Didi
- Jonathan Kadishson, Burns & McDonnell
- Julissa Mateo Abad, Bunker
- Kamil Mroz, UCB
- Kaspar Korjus, PactumAI
- Katerina Treppeschova, Facebook
- Kenneth Harris II, NASA
- Laura Jones, Special Olympics
- Leanne Pittsford, Include.io/Lesbians Who Tech
- Lijuan Gao, NICE
- Marina Tranchitella, Sport Club Internacional
- Miishe Addy, Jetstream Africa
- Pascale Sablan, S9 Architecure
- Rajesh Kumar Nalla, Techimax IT
- Prime Minster Sanna Marin, Government of Finland
- Sevi Rich, BHP
- Sitanshu Dash, Adobe
- Stephen Xu, Alibaba
- Taiwo Abraham, Horizant
- Tamara Kotevska, Documentary Producer
- Tiago Chavez Oliveira, Government of Brazil
- Tim Kaltwasser, Airbus
- Vidhya Abhjith, Codewave Tech
- Vihari Kanukollu, UrbanKisaan
- Wanja Murekio, Safaricom
- Whitney Wolfe Herd, Bumble
- Ye Fei, ZTE
- Yingjin Liu, DSM
- Yoftahe Yohannes, Ericsson
*All product names, logos, and brands are the property of their respective owners
About Project Management Institute (PMI)
Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams. Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org, www.projectmanagement.com www.facebook.com/PMInstitute and on Twitter @PMInstitute.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200713005075/en/
Contact information
Rachael Ballard, 443-618-7014
rachael.ballard@pmi.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release
Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom